Northwestern Medicine investigators led by Amy Heimberger, MD, Ph.D., the Jean Malnati Miller Professor of Brain Tumor Research and vice chair for Research in the Department of Neurological Surgery, have discovered a new ...
Mar 21, 2024
0
0
Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit ...
Mar 20, 2024
0
89
A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumors has now been proven effective for breast cancer patients with large tumors, providing a new treatment path for those who are not candidates ...
Mar 20, 2024
0
0
Scientists from Universidad Carlos III de Madrid (UC3M) and Johns Hopkins University (JHU), in the U.S., have analyzed the growth of breast tumors from a biomechanical perspective and have created a computational model that ...
Mar 20, 2024
0
0
Killing off large tumors by freezing them could become an effective means of fighting difficult-to-treat breast cancer, a new study says.
Mar 20, 2024
0
0
Traditionally, therapies combining DNA-damaging agents and STING agonists have shown potential in treating cancer by enhancing immune response and reshaping the tumor microenvironment. However, until now, creating a single ...
Mar 20, 2024
0
0
When Herve found out he had glioblastoma—the most aggressive form of brain cancer—at the age of 40, he made a deal with himself.
Mar 20, 2024
0
0
Removal of cancerous tumors, or resection, in delicate areas like the head and neck is a challenge for even the most experienced surgeons. When removing cancerous tissue, the aim is to preserve as much healthy tissue as possible ...
Mar 19, 2024
0
34
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein. Scientists at St. Jude Children's ...
Mar 19, 2024
0
55
Jonathan Chen, MD, Ph.D., an investigator in the Department of Pathology at Massachusetts General Hospital, and Nir Hacohen, Ph.D., director of the Center of Cancer Immunology at Massachusetts General Hospital, are co-authors ...
Mar 19, 2024
0
0
